Literature DB >> 30761980

Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Flaviane Alves de Pinho1,2, Célia Maria Vieira Vendrame1, Bruna Leal Lima Maciel3, Lucilene Dos Santos Silva4, Samantha Ive Miyashiro5, Selma Maria Bezerra Jerônimo6,7, Hiro Goto8,1.   

Abstract

We analyzed the association between insulin-like growth factor-I (IGF-I) and the pathogenesis of anemia during active visceral leishmaniasis (VL). Serum levels of IGF-I, IGF-binding protein 3 (IGFBP3), and cytokines were measured in samples from individuals with active VL and cured VL, asymptomatic Leishmania-infected, and noninfected individuals. Then, we extended our analysis to VL dogs to evaluate hematimetric parameters, bone marrow alterations, and cytokine and IGF-I expression. We identified a positive correlation between lower IGF-I and IGFBP3 levels in active VL patients and lower hemoglobin levels. In infected dogs, there was a positive correlation between lower IGF-I expression in the bone marrow and lower peripheral blood hematocrit and hemoglobin levels. There was no correlation between decreased IGF-I level/expression and any measured cytokine serum levels in either host. The data suggest that low IGF-I expression is associated with pathogenesis of anemia in active VL, primarily in severe cases, by mechanisms other than alterations in cytokine production.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30761980      PMCID: PMC6447109          DOI: 10.4269/ajtmh.17-0982

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

Review 1.  The insulin-like growth factor system in hematopoietic cells.

Authors:  Walter Zumkeller
Journal:  Leuk Lymphoma       Date:  2002-03

2.  Tumor necrosis factor α-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression.

Authors:  Christine Grigorakaki; Franck Morceau; Sébastien Chateauvieux; Mario Dicato; Marc Diederich
Journal:  Biochem Pharmacol       Date:  2011-04-09       Impact factor: 5.858

3.  Effect of recombinant human growth hormone (rhGH) on hemoglobin concentration in children with idiopathic growth hormone deficiency-related anemia.

Authors:  Roberto Miniero; Federica Altomare; Mario Rubino; Patrizia Matarazzo; Claudio Montanari; Antonella Petri; Giuseppe Raiola; Gianni Bona
Journal:  J Pediatr Hematol Oncol       Date:  2012-08       Impact factor: 1.289

Review 4.  Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.

Authors:  Jason C O'Connor; Robert H McCusker; Klemen Strle; Rodney W Johnson; Robert Dantzer; Keith W Kelley
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

5.  Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level.

Authors:  S Arkins; N Rebeiz; D L Brunke-Reese; A Biragyn; K W Kelley
Journal:  Mol Endocrinol       Date:  1995-03

6.  Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.

Authors:  Joanna R Santos-Oliveira; Eduardo G Regis; Cássia R B Leal; Rivaldo V Cunha; Patrícia T Bozza; Alda M Da-Cruz
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

7.  CD4+ T Cells Alter the Stromal Microenvironment and Repress Medullary Erythropoiesis in Murine Visceral Leishmaniasis.

Authors:  Olivier Preham; Flaviane A Pinho; Ana Isabel Pinto; Gulab Fatima Rani; Najmeeyah Brown; Ian S Hitchcock; Hiro Goto; Paul M Kaye
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

8.  Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen.

Authors:  William P Lafuse; Ryan Story; Jocelyn Mahylis; Gaurav Gupta; Sanjay Varikuti; Heidi Steinkamp; Steve Oghumu; Abhay R Satoskar
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

9.  MicroRNA expression profile in human macrophages in response to Leishmania major infection.

Authors:  Julien Lemaire; Ghada Mkannez; Fatma Z Guerfali; Cindy Gustin; Hanène Attia; Rabiaa M Sghaier; Koussay Dellagi; Dhafer Laouini; Patricia Renard
Journal:  PLoS Negl Trop Dis       Date:  2013-10-03

10.  Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.

Authors:  Márcia Dias Teixeira Carvalho; Diego Peres Alonso; Célia Maria Vieira Vendrame; Dorcas Lamounier Costa; Carlos Henrique Nery Costa; Guilherme Loureiro Werneck; Paulo Eduardo Martins Ribolla; Hiro Goto
Journal:  Mediators Inflamm       Date:  2014-08-27       Impact factor: 4.711

View more
  2 in total

1.  Mathematical Modelling Using Predictive Biomarkers for the Outcome of Canine Leishmaniasis upon Chemotherapy.

Authors:  Rafaela de Sousa Gonçalves; Flaviane Alves de Pinho; Ricardo Jorge Dinis-Oliveira; Rui Azevedo; Joana Gaifem; Daniela Farias Larangeira; Eduardo Milton Ramos-Sanchez; Hiro Goto; Ricardo Silvestre; Stella Maria Barrouin-Melo
Journal:  Microorganisms       Date:  2020-05-15

Review 2.  Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fernanda N Araujo; Ariane F Leal; Christiane Y Ozaki; Orlando R Sevillano; Bernardina A Uscata; Hiro Goto
Journal:  J Immunol Res       Date:  2021-05-04       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.